Lennon Search Associates Blog Neos angles for a $74M IPO to fund its ADHD drugs

Neos Therapeutics spelled out the terms of its pending IPO, lining up for as much as $73.6 million as it moves forward with reformulated versions of common ADHD treatments. ...read more Source: Neos angles for a $74M IPO to fund its ADHD drugs